Telix to raise $300m and set to list on Nasdaq
MELBOURNE: Telix Pharmaceuticals, the developer of cancer treatments and a favourite of local fund managers,
MELBOURNE: Telix Pharmaceuticals, the developer of cancer treatments and a favourite of local fund managers,